Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis.
about
Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesisHuman papillomavirus and cervical cancer: biomarkers for improved prevention effortsEpigenetic impact of infection on carcinogenesis: mechanisms and applicationshTERT promoter activity and CpG methylation in HPV-induced carcinogenesisEpigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population.Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer.HPV type-related chromosomal profiles in high-grade cervical intraepithelial neoplasia.Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test.Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis.Academic College of Emergency Experts in India's INDO-US Joint Working Group and OPUS12 Foundation Consensus Statement on Creating A Coordinated, Multi-Disciplinary, Patient-Centered, Global Point-of-Care Biomarker Discovery NetworkEpigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma.Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrapePromoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas.A promising DNA methylation signature for the triage of high-risk human papillomavirus DNA-positive womenHPV16 Down-Regulates the Insulin-Like Growth Factor Binding Protein 2 to Promote Epithelial Invasion in Organotypic Cultures.DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive womenHPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications.Suppression of MAL gene expression is associated with colorectal cancer metastasis.Longitudinal assessment of DNA methylation changes during HPVE6E7-induced immortalization of primary keratinocytes.Methylation analysis and HPV genotyping of self-collected cervical samples from women not responding to screening invitation and review of the literature.Methylation-mediated transcriptional repression of microRNAs during cervical carcinogenesis.JAM3 methylation status as a biomarker for diagnosis of preneoplastic and neoplastic lesions of the cervixAberrant methylation of LINE-1, SLIT2, MAL and IGFBP7 in non-small cell lung cancer.Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer.Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive womenMAL hypermethylation is a tissue-specific event that correlates with MAL mRNA expression in esophageal carcinoma.Decreased MALL expression negatively impacts colorectal cancer patient survivalAberrant methylation-mediated silencing of microRNAs contributes to HPV-induced anchorage independence.MAL and TMEM220 are novel DNA methylation markers in human gastric cancer.Performance of a new HPV and biomarker assay in the management of hrHPV positive women: Subanalysis of the ongoing multicenter TRACE clinical trial (n > 6,000) to evaluate POU4F3 methylation as a potential biomarker of cervical precancer and cancer.FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women.Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).CADM1 and MAL methylation status in cervical scrapes is representative of the most severe underlying lesion in women with multiple cervical biopsies.Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy.Upregulation of myelin and lymphocyte protein (MAL) after traumatic spinal cord injury in rats.Molecular events leading to HPV-induced high grade neoplasia.CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease.CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer.Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women.Potential new biomarkers for squamous carcinoma of the uterine cervix.
P2860
Q21134097-BE3289EB-549A-4F67-A2A5-B0D4CD83E434Q27023127-53C9B2C4-FB0D-4561-A8D7-9B34282F7313Q28066519-382986CF-B7A8-4F13-901F-D721E29287A4Q33599338-2EDC0A2E-2BD2-4816-A461-CDDE70F2AAE3Q33887581-E3C72A5F-A506-44F1-B9EE-6E2C303B89DAQ34049709-548DCF71-83D5-4E1E-B72F-A1A02A5046E5Q34138292-9EB44162-D210-4C0A-B20A-6B89AAA47CA8Q34250191-6E25FBBF-7391-482B-98EE-41E276D01220Q34254020-D8F34F6B-0683-425B-8E94-9DB9DE294BA5Q34357303-CDA731F2-6D42-4DF5-8548-F9CA038DE83AQ34410542-840C1073-AFD7-4770-A83B-10BB6ECDE685Q34486779-A894745B-B108-477F-B7BE-21909039B687Q35071360-C71ACCAE-24A9-4996-BC8F-A86C13CAFA0CQ35125113-408D1118-955B-4CA1-AC4A-BA80C4F97DFFQ35672982-18CFB751-006D-4851-95BC-40FB163CE5D7Q35678378-86CBE24C-35EA-4725-A81B-CF9CF5B0DD06Q35835143-AFD0F777-5314-4DB7-BB94-2F73251BABB0Q35871200-4B05C8AF-C5C1-4D0C-AEEE-E05F7C095F4DQ36212820-B8E8CBA1-E9D1-4FE9-9C49-45F78E8F03CDQ36298250-3CC7B169-F724-43A0-8DCE-D8A216D7A298Q36670003-F67A71AB-1AEF-4A92-9AA8-1C0C45644BD0Q36688981-0C6E5FA8-7188-4F83-BCBD-2EABDCC9B49AQ36753304-011CACD6-5766-43E2-8549-8C74190F5A9AQ36833399-D709A0CB-13FD-43C4-B55B-CD0F5D3E2325Q36852263-690884E4-FCB3-4F05-B2AD-70744C1E7CE2Q37211943-19608BF4-35B8-44F0-B70D-D1CDE2A9C531Q37225710-4A0276F0-A5EB-4CE0-B7E9-49367AA112E6Q37536706-367E94C7-1632-49E1-A315-B656140723BAQ38762957-64BEFCA2-78AC-4C34-9F2C-7BFA5D42A544Q40440825-F712C8BF-5961-4086-AE44-5C444F088070Q40651861-FA870FB5-5FAF-4A48-B34C-1336AB2A94A0Q41027688-C9666347-8DE5-426E-B48F-4AD710251300Q41538167-FB86292C-9AE4-42B3-9791-FE10BB250D10Q42240383-7CC75C81-0A41-46CC-92F2-60052DDD0D6AQ42517147-06B51A65-6965-4B8D-8DEA-106291D3BA8CQ47598990-0B677EB1-CE6F-49E4-BFA4-BC382B147F3CQ51827467-8CBCBD75-AB9F-442D-A9C1-F7AD2231CAB1Q53229949-6964B7EA-1ADA-41C5-9824-79FB0D7C89BDQ53291854-0D77A636-4C6A-47CB-986D-E40741EEDF58Q55715397-E0F95DF1-6692-4A33-A84B-03E43AFBFFC1
P2860
Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Repression of MAL tumour suppr ...... uring cervical carcinogenesis.
@en
Repression of MAL tumour suppr ...... uring cervical carcinogenesis.
@nl
type
label
Repression of MAL tumour suppr ...... uring cervical carcinogenesis.
@en
Repression of MAL tumour suppr ...... uring cervical carcinogenesis.
@nl
prefLabel
Repression of MAL tumour suppr ...... uring cervical carcinogenesis.
@en
Repression of MAL tumour suppr ...... uring cervical carcinogenesis.
@nl
P2093
P356
P1476
Repression of MAL tumour suppr ...... during cervical carcinogenesis
@en
P2093
Chris J L M Meijer
Florianne E Henken
Ilse Timmerman
Mariska Bierkens
Peter J F Snijders
Renée M Overmeer
P2860
P304
P356
10.1002/PATH.2598
P577
2009-11-01T00:00:00Z